Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Slides:

Advertisements

Similar presentations

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:

Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.

Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Figure 1. Disposition of study participants, by group. Data are no

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Figure 1. Antibody responses against homologous 2013 H7 virus in H7N9-infected patients. A, Serum samples from H7N9-infected patients were collected at.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

From: Clinical and Laboratory Diagnosis of Dengue Virus Infection

From: Rotarix: A Rotavirus Vaccine for the World

Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,

From: Postinfectious Irritable Bowel Syndrome

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Figure 1. Flowchart of study participants

Table 2. Mean intrasubject diversity for the 11 study participants, by genomic region. From: Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects.

Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis Nancy Simonney, Jean Michel Molina, Mathieu Molimard, Eric Oksenhendler,

Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis

I.J. Schalk Clinical Microbiology and Infection

Anna Tinnert, Annika Hamlet, Ann-Mari Svennerholm

E. Kunter, K. Cerrahoglu, A. Ilvan, T. Isitmangil, O. Turken, O

Atypical respiratory pathogens

Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study P. Turner, C.

R. Cantón Clinical Microbiology and Infection

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus P.-R. Hsueh, L.-M. Huang, P.-J.

Link between intracellular pathogens and cardiovascular diseases

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

J. Zhang, X. -F. Zhang, C. Zhou, Z. -Z. Wang, S. -J. Huang, X. Yao, Z

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Serological responses to Cryptosporidium in human populations living in areas reporting high and low incidences of symptomatic cryptosporidiosis K. Elwin,

Rotavirus vaccination: a concise review

CMI editorial report 2011 Clinical Microbiology and Infection

Z. Wang, Z. Cui, Y. Li, T. Hou, X. Liu, Y. Xi, Y. Liu, H. Li, Q. He

Anna Tinnert, Annika Hamlet, Ann-Mari Svennerholm

Bacterial resistance—the clinical challenge

Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes S. Ladhani,

Can we control all-cause meningococcal disease in Europe?

Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years T.G. Harrison, N. Doshi, N.K. Fry, C.A.

Meningococcal group C disease in Greece during 1993–2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians D.A.

Detection of specific IgM antibody in the investigation of an outbreak of pneumonia due to Legionella pneumophila serogroup 1 F. de Ory, J.M. Echevarría,

L. Arreaza, J.A. Vázquez Clinical Microbiology and Infection

Table 4. Comparison of screening guidelines in terms of the total number and percentages of patients screened for ... Table 4. Comparison of screening.

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

Abstracts cont. Clinical Microbiology and Infection

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection R. Nir-Paz, A. Michael-Gayego, M. Ron, C.

Vaccinations against respiratory tract infections at Hajj

D. Hvidsten, D.S. Halvorsen, B.P. Berdal, T.J. Gutteberg

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Clinical Microbiology and Infection

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

C.P. Kelly Clinical Microbiology and Infection

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

S.J.P. Warren, L.A. Arteaga, L.A. Diaz

Fig. 4. Reverse cumulative distribution curve of serum bactericidal indices against serogroup A, C, W-135, and Y at baseline and post-immunization (1 month.

Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients Suresh Pallikkuth, PhD, Sudheesh Pilakka.

Complementary algorithm for serological testing of specimens with an initial IgM-positive or indeterminate result 5 Collect an adequate serum sample within.

Presentation transcript:

Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent serum samples from subjects with vaccine failure (F) and control subjects (C). From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12):1745-1752. doi:10.1086/509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

Table 3. Immunoglobulin isotype and subclass deficiency in convalescent serum samples from subjects with vaccine failure, compared with those in unvaccinated subjects with meningococcal serogroup C disease. From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12):1745-1752. doi:10.1086/509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

Table 2. Demographic details of the subjects with vaccine failure and unvaccinated control subjects. From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12):1745-1752. doi:10.1086/509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.

Table 1. Classification by vaccination status of 462 subjects with confirmed meningococcal serogroup C (MenC) disease, in England and Wales between January 2000 and December 2003. From: Clinical and Immunologic Risk Factors for Meningococcal C Conjugate Vaccine Failure in the United Kingdom J Infect Dis. 2006;194(12):1745-1752. doi:10.1086/509619 J Infect Dis | © 2006 by the Infectious Diseases Society of America. All rights reserved.